Absal Pharma Global Private Limited
About Absal Pharma Global Private Limited
Data last updated:
Absal Pharma Global Private Limited is a private limited company based in Yarandahalli Village, Karnataka, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2020PTC142633.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹28.51 Lakh. It is led by directors Abdulsalam Abdulrahuman Kunju and Mohammed Ameen Abdul Salam.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No.1&2 No.80/2 Anekal Taluk, Yarandahalli Village, Karnataka, India – 560105.
As per the financials filed for FY 2024, the company reported a revenue of ₹28.56 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.1 Lakh (net margin -3.8%) and EBITDA of -₹89,529 (EBITDA margin -3.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No.1&2 No.80/2 Anekal Taluk, Yarandahalli Village, Karnataka, India – 560105
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Absal Pharma Global Private Limited
The main business activity of Absal Pharma Global is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Absal Pharma Global Private Limited FY 2024 filings available
Absal Pharma Global Private Limited reported revenue of ₹28.56 Lakh (up 697% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Absal Pharma Global Private Limited
Revenue rose 697% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Absal Pharma Global Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹89,529 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.1 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Absal Pharma Global Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -3.1% | •••• | •••• | •••• |
| Net Profit Margin | -3.8% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Absal Pharma Global are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Absal Pharma Global Private Limited
Absal Pharma Global Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Redizen Lifesciences Private Limited | ₹28.71 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Hyderabad, Telangana, India |
| F3 Biotechnology Private Limited | ₹28.67 Lakh (FY 2024) | •••• | •••• | 49.0% | •••• | Dehradun, Uttarakhand, India |
| Goclean Products Private Limited | ₹28.65 Lakh (FY 2024) | •••• | •••• | -15.0% | •••• | Bangalore, Karnataka, India |
| Ansturm Health Care Private Limited | ₹28.59 Lakh (FY 2020) | •••• | •••• | -3.0% | •••• | Sulthan Bathery, Kerala, India |
| Jeevan Treads Private Limited | ₹28.58 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Thrissur, Kerala, India |
| Absal Pharma Global Private Limited this company | ₹28.56 Lakh (FY 2024) | •••• | •••• | 697.0% | •••• | Yarandahalli Village, Karnataka, India |
| Azure Laboratories Private Limited | ₹28.52 Lakh (FY 2019) | •••• | •••• | -31.0% | •••• | Ernakulam, Kerala, India |
| Hva Chemical Solution Private Limited | ₹28.51 Lakh (FY 2025) | •••• | •••• | 100.0% | •••• | Paramakudi, Tamil Nadu, India |
| Nerib Life Science Private Limited | ₹28.5 Lakh (FY 2024) | •••• | •••• | 34.0% | •••• | Opt. Akh, Gujarat, India |
| A-One Dyes and Chemicals Pvt Ltd | ₹28.46 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Susruta Biotech Private Limited | ₹28.44 Lakh (FY 2021) | •••• | •••• | 3.0% | •••• | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Absal Pharma Global by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Absal Pharma Global Private Limited
Absal Pharma Global has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abdulsalam Abdulrahuman Kunju Also directs: Medzolaze Pharma LLP | Director | 25 Dec 2020 | 5 Years 9 Months | Current |
| Mohammed Ameen Abdul Salam Also directs: Medzolaze Pharma LLP | Director | 25 Dec 2020 | 5 Years 9 Months | Current |
Charges & Borrowings of Absal Pharma Global Private Limited
Absal Pharma Global Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Absal Pharma Global Private Limited
Employment history and EPFO contributions of people linked to Absal Pharma Global.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Absal Pharma Global Private Limited
Absal Pharma Global Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Abdulsalam Abdulrahuman Kunju was appointed as Director on 25 Dec 2020.
Credit Ratings, Litigation & Regulatory Alerts for Absal Pharma Global Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Absal Pharma Global Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Absal Pharma Global Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Absal Pharma Global Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Absal Pharma Global Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Absal Pharma Global Private Limited
Absal Pharma Global is an active private limited company based in Yarandahalli Village, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 December 2020 (6+ years old) and is registered under CIN U24290KA2020PTC142633.
Absal Pharma Global reported revenue of ₹28.56 Lakh for FY 2024 (up 697% YoY).
Absal Pharma Global has 2 current directors:
- Abdulsalam Abdulrahuman Kunju - Director
- Mohammed Ameen Abdul Salam - Director
Absal Pharma Global reported a net loss of ₹1.1 Lakh (net margin -3.8%) and EBITDA of -₹89,529 (EBITDA margin -3.1%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Absal Pharma Global is U24290KA2020PTC142633. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Absal Pharma Global was incorporated on 25 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Absal Pharma Global by revenue are Redizen Lifesciences Private Limited, F3 Biotechnology Private Limited, Goclean Products Private Limited, Ansturm Health Care Private Limited, Jeevan Treads Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Abdulsalam Abdulrahuman Kunju was appointed as Director on 25 Dec 2020. Mohammed Ameen Abdul Salam was appointed as Director on 25 Dec 2020.
The registered office of Absal Pharma Global is at Shop No.1&2 No.802 Anekal Taluk, Yarandahalli Village, Karnataka, India – 560105.
Absal Pharma Global has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹28.51 Lakh.
Absal Pharma Global operates in the chemicals industry, in the manufacturing segment.